ROCHE

Company number 0403.088.151

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 7
Shared contracts: 6 (multi-supplier framework agreements)
Period: 26 January 2024 – 7 April 2026

Its main clients

VITAZ vzw · 2 contracts
AZ Delta vzw · 1 contract
Universitair Ziekenhuis Gent · 1 contract
VZW Maria Middelares · 1 contract
Vivalia · 1 contract
Hospilim VZW · 1 contract

Where and what

Supplies · 7

East Flanders · 4 West Flanders · 1 Limburg · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
12 December 2027 re-tender around June 2027	Raamovereenkomst voor het leveren van Cytostatica Parenteraal Hospilim VZW framework agreement	Roche NV Accord Healthcare BV Celltrion Healthcare Netherlands BV Pharmanovia Benelux BV Viatris BV Fresenius Kabi NV Baxter Belgium SRL Aurobindo NV AstraZeneca NV Arega Pharma BV Servier Benelux NV MSD Belgium BV Sandoz NV 4 bids received	€375,000,000
26 July 2028 re-tender around January 2028	Monoklonale antilichamen - Trastuzumab 2024 VITAZ vzw framework agreement	Celltrion Healthcare Netherlands B.V. ROCHE SA 1 bid received	€2,362,513
26 July 2028 re-tender around January 2028	Monoklonale antilichamen - Rituximab 2024 VITAZ vzw framework agreement	Celltrion Healthcare Netherlands B.V. ROCHE SA 2 bids received	€1,200,479
18 February 2029 re-tender around August 2028	Raamovereenkomst voor het leveren van rituximab en trastuzumab Universitair Ziekenhuis Gent framework agreement	Sandoz nv Roche Celltrion Healthcare Netherlands 4 bids received	€8,618,346

Contracts won

Date	Contract	Buyer	Amount
07/04/2026	Parenterale cytostatica	AZ Delta vzw	€3,950,688 shared by 12
14/04/2025	Raamovereenkomst voor het leveren van rituximab en trastuzumab	Universitair Ziekenhuis Gent	€8,618,346 shared by 3
26/08/2024	Raamovereenkomst voor het aankopen en leveren van Trastuzumab en Rituximab	VZW Maria Middelares	€13,660,477 shared by 3
23/07/2024	Accord-cadre relatif à la fourniture de RITUXIMAB et de TRASTUZUMAB pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats	Vivalia	–
28/05/2024	Monoklonale antilichamen - Trastuzumab 2024	VITAZ vzw	€2,362,513 shared by 2
28/05/2024	Monoklonale antilichamen - Rituximab 2024	VITAZ vzw	€1,200,479 shared by 2
26/01/2024	Raamovereenkomst voor het leveren van Cytostatica Parenteraal	Hospilim VZW	€375,000,000 shared by 13

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.